1Jing H, Linj J, Tao J, et al. Suppression of human ribsomae protein L23A expression during cell growth inhibition by IFN-β[J]. Oncogene,1997,14(4) :473-476.
2Saily M, Koistenen P, Soppi E, et al. Effect of interferon-alpha on immunoglobulin production by peripheral blood mononuclear cells in multiple milkman[J]. Eur J Haematol, 1996,57(2) : 171-173.
3Strander H, Bauer HC, Brosjo O, et al. Long-term adjuvant interferon treatment of human osteosarcoma : A pilot study[ J ]. Actaoncol, 1995,34 : 877-880.
4Chu E, Zinn S, Boarman D, et al. Interaction of γ-interferon and 5-fluorouracil in the H630 human colon carcinoma cell line[ J ]. Cancer Res, 1990,50 ; 5834-5840.
3Marzolini C,Paus E,Buclin T,et al.Polymorphisms in humanMDR-1(P-glycoprotein): Recent advances and clinical relevance[J].Clin Pharmacol Ther, 2004, 75(1):13-33.
4Anthony V,Skach W R.Molecular mechanism of P-glycoproteinassembly into cellular membranes[J].Curr Protein Pept Sci,2002, 3(5); 485-501.
5Volm M, Koomagi R, Mattem J, et al.Prognostic value of basicfibroblast growth factor and its receptor(FGFR-1)in patients withnon-small cell lung carcinomas[J].Eur J Cancer, 1997 , 33(3):691-693.
6Ferguson LA,Rhoads J.Multidrug-resistant and extensively drug-resistant tuberculosis:The new face of an old disease[J].J AmAcad Nurse Pract, 2009 , 21(11):603-609.
